Advertisement
Home Tags Health Costs

Tag: Health Costs

The costs associated with low-cost

Low-Cost Services a Major Player in Unnecessary Health Spending

Costs associated with low-cost, low-value health services nearly twice as high as high-cost services
Nocebo hyperalgesia is stronger when an inert treatment is labeled as being an expensive medication rather than a cheap one

Stronger Nocebo Effect When Inert Rx Labeled As Expensive

Neural interactions between cortex, brainstem, and spinal cord mediate this effect
For low-income adults

Participation in SNAP Can Cut Health Care Expenditures

In fully adjusted models, SNAP linked to lower annual health care expenditure for low-income adults
Insurers have the bargaining power to reduce provider prices in highly concentrated provider markets

Insurer Market Power Lowers Providers’ Prices

Evidence seen for specialists in markets with high provider, insurer concentration
The median cost of cancer drug development is $648.0 million

Median Cost of Cancer Drug Development $648.0 Million

Total revenue from sales of 10 drugs was $67.0 billion, with total R&D spending of $7.2 billion
At its current price

More Evidence Evolocumab Exceeds Cost-Effectiveness

Findings for addition of evolocumab to standard tx in atherosclerotic cardiovascular disease
The costs of PCSK9 inhibitors would have to be 71 percent lower to be deemed cost-effective

Cost-Effectiveness of PCSK9 Inhibitors Called Into Question

Researchers say price would have to be between $4,000 and $5,000 per year to be cost-effective
Lifetime costs of care are substantially increased for individuals with dementia

Families Shoulder Majority of Costs Related to Dementia Care

Reducing functional decline or behavioral and psychological symptoms leads to lower lifetime costs
The cost burden associated with vitiligo is high

Limited Economic Evidence for Vitiligo Treatments

Research reveals no evidence to support or refute value for money afforded by vitiligo treatments
Increases in the price of nitroprusside and isoproterenol correlated with reductions in their use

Nitroprusside, Isoproterenol Prescribing Drops With Price Rise

Decrease in absolute number of patients treated from 2012 to 2015 with major increase in price